Choosing and switching biological agents in severe asthma

Respirology. 2022 Nov;27(11):926-928. doi: 10.1111/resp.14377. Epub 2022 Sep 26.

Authors

Muhammad Adrish¹, Nicola A Hanania¹

Affiliation

¹ Section of Pulmonary & Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

PMID: 36161677
DOI: 10.1111/resp.14377

No abstract available

Keywords: asthma control; asthma exacerbations; biologics; severe asthma; type 2 inflammation.

MeSH terms

Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Biological Factors / therapeutic use
Humans

Substances

Anti-Asthmatic Agents
Biological Factors